Literature DB >> 20064933

Glutamine synthetase in muscle is required for glutamine production during fasting and extrahepatic ammonia detoxification.

Youji He1, Theodorus B M Hakvoort, S Eleonore Köhler, Jacqueline L M Vermeulen, D Rudi de Waart, Chiel de Theije, Gabrie A M ten Have, Hans M H van Eijk, Cindy Kunne, Wilhelmina T Labruyere, Sander M Houten, Milka Sokolovic, Jan M Ruijter, Nicolaas E P Deutz, Wouter H Lamers.   

Abstract

The main endogenous source of glutamine is de novo synthesis in striated muscle via the enzyme glutamine synthetase (GS). The mice in which GS is selectively but completely eliminated from striated muscle with the Cre-loxP strategy (GS-KO/M mice) are, nevertheless, healthy and fertile. Compared with controls, the circulating concentration and net production of glutamine across the hindquarter were not different in fed GS-KO/M mice. Only a approximately 3-fold higher escape of ammonia revealed the absence of GS in muscle. However, after 20 h of fasting, GS-KO/M mice were not able to mount the approximately 4-fold increase in glutamine production across the hindquarter that was observed in control mice. Instead, muscle ammonia production was approximately 5-fold higher than in control mice. The fasting-induced metabolic changes were transient and had returned to fed levels at 36 h of fasting. Glucose consumption and lactate and ketone-body production were similar in GS-KO/M and control mice. Challenging GS-KO/M and control mice with intravenous ammonia in stepwise increments revealed that normal muscle can detoxify approximately 2.5 micromol ammonia/g muscle.h in a muscle GS-dependent manner, with simultaneous accumulation of urea, whereas GS-KO/M mice responded with accumulation of glutamine and other amino acids but not urea. These findings demonstrate that GS in muscle is dispensable in fed mice but plays a key role in mounting the adaptive response to fasting by transiently facilitating the production of glutamine. Furthermore, muscle GS contributes to ammonia detoxification and urea synthesis. These functions are apparently not vital as long as other organs function normally.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064933      PMCID: PMC2843202          DOI: 10.1074/jbc.M109.092429

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

Review 2.  The glucose-alanine cycle.

Authors:  P Felig
Journal:  Metabolism       Date:  1973-02       Impact factor: 8.694

3.  Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2-3 microns Spherisorb ODS II column.

Authors:  H M van Eijk; D R Rooyakkers; N E Deutz
Journal:  J Chromatogr       Date:  1993-10-22

4.  The origin of alanine produced in skeletal muscle.

Authors:  T W Chang; A L Goldberg
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

5.  Inhibition of muscle glutamine formation in hypercatabolic patients.

Authors:  G Biolo; R Y Fleming; S P Maggi; T T Nguyen; D N Herndon; R R Wolfe
Journal:  Clin Sci (Lond)       Date:  2000-09       Impact factor: 6.124

6.  Physiological hypercortisolemia increases proteolysis, glutamine, and alanine production.

Authors:  D Darmaun; D E Matthews; D M Bier
Journal:  Am J Physiol       Date:  1988-09

7.  Expression, purification, and characterization of recombinant human glutamine synthetase.

Authors:  C D Listrom; H Morizono; B S Rajagopal; M T McCann; M Tuchman; N M Allewell
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

8.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

Review 9.  Glutamine: recent developments in research on the clinical significance of glutamine.

Authors:  Gerdien C Melis; Nathalie ter Wengel; Petra G Boelens; Paul A M van Leeuwen
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2004-01       Impact factor: 4.294

10.  Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man.

Authors:  N Nurjhan; A Bucci; G Perriello; M Stumvoll; G Dailey; D M Bier; I Toft; T G Jenssen; J E Gerich
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

View more
  36 in total

1.  Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase.

Authors:  Natalia Qvartskhava; Philipp A Lang; Boris Görg; Vitaly I Pozdeev; Marina Pascual Ortiz; Karl S Lang; Hans J Bidmon; Elisabeth Lang; Christina B Leibrock; Diran Herebian; Johannes G Bode; Florian Lang; Dieter Häussinger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

2.  Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations.

Authors:  Qiuying Chen; Kathryne Kirk; Yevgeniya I Shurubor; Dazhi Zhao; Andrea J Arreguin; Ifrah Shahi; Federica Valsecchi; Guido Primiano; Elizabeth L Calder; Valerio Carelli; Travis T Denton; M Flint Beal; Steven S Gross; Giovanni Manfredi; Marilena D'Aurelio
Journal:  Cell Metab       Date:  2018-04-12       Impact factor: 27.287

3.  Expression of Glutamate Transporters in Mouse Liver, Kidney, and Intestine.

Authors:  Qiu Xiang Hu; Sigrid Ottestad-Hansen; Silvia Holmseth; Bjørnar Hassel; Niels Christian Danbolt; Yun Zhou
Journal:  J Histochem Cytochem       Date:  2018-01-05       Impact factor: 2.479

4.  Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models.

Authors:  Roula Tsonaka; Mirko Signorelli; Ekrem Sabir; Alexandre Seyer; Kristina Hettne; Annemieke Aartsma-Rus; Pietro Spitali
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

5.  The effect of hyperammonemia on myostatin and myogenic regulatory factor gene expression in broiler embryos.

Authors:  R A Stern; C M Ashwell; S Dasarathy; P E Mozdziak
Journal:  Animal       Date:  2015-02-18       Impact factor: 3.240

6.  Secondary NAD+ deficiency in the inherited defect of glutamine synthetase.

Authors:  Liyan Hu; Khalid Ibrahim; Martin Stucki; Michele Frapolli; Noora Shahbeck; Farrukh A Chaudhry; Boris Görg; Dieter Häussinger; W Todd Penberthy; Tawfeg Ben-Omran; Johannes Häberle
Journal:  J Inherit Metab Dis       Date:  2015-04-21       Impact factor: 4.982

7.  Delivery of glutamine synthetase gene by baculovirus vectors: a proof of concept for the treatment of acute hyperammonemia.

Authors:  M A Torres-Vega; R Y Vargas-Jerónimo; A G Montiel-Martínez; R M Muñoz-Fuentes; A Zamorano-Carrillo; A R Pastor; L A Palomares
Journal:  Gene Ther       Date:  2014-10-23       Impact factor: 5.250

8.  Ammonia elicits a different myogenic response in avian and murine myotubes.

Authors:  Rachel A Stern; Srinivasan Dasarathy; Paul E Mozdziak
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-08-29       Impact factor: 2.416

9.  Serum glutamine, set-shifting ability and anorexia nervosa.

Authors:  Michiko Nakazato; Kenji Hashimoto; Ulrike Schmidt; Kate Tchanturia; Iain C Campbell; David A Collier; Masaomi Iyo; Janet Treasure
Journal:  Ann Gen Psychiatry       Date:  2010-06-25       Impact factor: 3.455

10.  Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway.

Authors:  Benjamin Lauzier; Fanny Vaillant; Clemence Merlen; Roselle Gélinas; Bertrand Bouchard; Marie-Eve Rivard; Francois Labarthe; Vern W Dolinsky; Jason R B Dyck; Bruce G Allen; John C Chatham; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2012-11-28       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.